KAYE RANDALL (CMO) sold 48.2% of their position (16.67K shares) of LONGBOARD PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $527.3K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
Common Stock
Shares
+16.67K
Price / share
$4.35
Trade value
$72.50K
% of position
Common Stock
Shares
−9.37K
Price / share
$30.89
Trade value
$289.28K
% of position
Common Stock
Shares
−4.20K
Price / share
$31.81
Trade value
$133.62K
% of position
Common Stock
Shares
−1.20K
Price / share
$33.12
Trade value
$39.75K
% of position
Common Stock
Shares
−1.90K
Price / share
$34.04
Trade value
$64.67K
% of position
Net shares
+0.00
Net value
-$454.82K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/16/2024 | M · Option Exercise | +16.67K | $4.35 | $72.50K | 93.0% | 17.92K | 34.59K |
| Common Stock Direct | 9/16/2024 | S · Sale | −9.37K | $30.89 | $289.28K | 27.1% | 34.59K | 25.22K |
| Common Stock Direct | 9/16/2024 | S · Sale | −4.20K | $31.81 | $133.62K | 16.7% | 25.22K | 21.02K |
| Common Stock Direct | 9/16/2024 | S · Sale | −1.20K | $33.12 | $39.75K | 5.7% | 21.02K | 19.82K |
| Common Stock Direct | 9/16/2024 | S · Sale | −1.90K | $34.04 | $64.67K | 9.6% | 19.82K | 17.92K |
| Total | +0.00 | -$454.82K | ||||||
Stock Option (Right to Buy)
Common Stock
16.67K shares
Shares
−16.67K
Strike price
4.35
Held after
112.97K
Exercisable
—
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock16.67K shares | 9/16/2024 | M · Option Exercise | −16.67K | 4.35 | — | 112.97K |